New Delhi: Ace Investor Rakesh Jhunjhunwala-Promoted Star Health and Allied Insurance Company has a weak debut on the stock exchange because of the stock listed with a 6 percent discount on December 10.
The company’s IPO also received a muted response due to worries.
Stock opened at RS 848 in BSE, down from the problem of the price of Rs 900, while the opening price on the national stock exchange is Rs 845.
However, the stock recovered in a few minutes and jumped almost 43 higher around RS 932 around.
10:30 a.m.
A day in front of listings, Star Health shares traded at 70-75 RS discounts per share in the Gray Market.
Star Health IPO, which is open for offers from November 30 to December 2, see a total subscription of 79 percent, accepting offers for 3.6 crore shares as offered by 4.5 crore shares.
The company has provided IPO prices between Rs 870-900 per share.
Institutional investors and bidders HNI gave IPO lost despite ‘subscribing’ from analysts.
“IPO star health insurance gets a bad response because of expensive assessment, therefore, we see a bad list.
Long-term prospects for industrial and star health insurance promising therefore we can expect buying interest at a lower level but it is difficult to say The right rate Star Health cut off the offer for sale (ofs) size to 4,400 crore from Rs 5,249 Crore after initial public offering received a bad response during its subscription period.
“Expensive valuation and dents in profitability because Covid19 is the main problem for investors.
However, the long-term outlook for the company is bullish thanks to the strong brand name and low penetration of health insurance in India.
Investors who register for this IPO for listings Gain can come out while investors can come out Long-term must maintain the patience and hold this stock.
New investors can wait some time before taking entries because we must understand that at what level, the market will be comfortable, “said Parth, Founder, Tradingo.” The problem is registered at RS 845 and now Traded at Rs 902.55.
There are several fresh purchases today because the increase in stabs comes with an increase in substantial volume.
Investors who subscribe to problems solely for the list of advantages must be disappointed because they are registered with a discounted price.
Despite increasing demand for the insurance industry and increased penetration is a factor support for industry, more b Aik to avoid buying this share because his assessment seems to be at a higher tip, “said Likhita Chepa, senior research analyst at Capitalvia Global Research.
Manoj Dalmia, Founder & Director in advanced equity recommends immediate sales.
“We expect the Star Health insurance stock price to fall like Paytm stock post-listings.
Buy at Star Health Share with a fair assessment or a lower price suggested.” Incorporated in 2006, Star Health is one of the largest private health insurance companies in India With a market share of 15.8 percent in fiscal year 2021, mainly focuses on retail health and mainly focuses on retail health and mainly focuses on retail health and focuses on retail health.
The group health segment that contributed 89.3 percent and 10.7 percent of the total GWP company (Premium written dirty).
In September 2021, the network distribution included 779 health insurance branches in 25 states and five union areas.
Posted by a pandemic after a pandemic, leading to increasing claims.
The company reported the loss of Rs 380.27 Crore in six months to 30 September, in addition to RS 825.58 Crore loss on FY21.
Aprajita Saxena, research analyst, “Star Health is one of the largest private health workers in India with a market share of 15.8 percent in FY21 & has the largest distribution network, a diverse product suite.
However, it has deteriorated financial metrics as shown by Losses on FY21 and H1 FY22.
Assessment-wise, the health of the star seems to be considered too high compared to the peer of his average peer, “Choice Broking said.
Why Star Health Supported by Jhunjhunwala Registered with a 6% discount
